Drug
mosunetuzumab
Marketed as LUNSUMIO.
Generic name
mosunetuzumab
Brand names
LUNSUMIO
First FDA approval
2022-12-22
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761263 | LUNSUMIO | 2022-12-22 | GENENTECH INC |
Manufacturers
GENENTECH INC
Frequently asked questions
When was mosunetuzumab FDA approved?
Earliest FDA approval on record: 2022-12-22.
What brand names are sold as mosunetuzumab?
LUNSUMIO.
Sources
Appeal a mosunetuzumab denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com